Conquering Diseases

A Follow On Study for People with Crohn’s Disease who Joined Earlier Studies of SHP647.

Description

Seeking patients with moderate to severe Crohn’s Disease. This study tests two amounts (doses) of a drug by monthly injection compared with a fake injection (placebo).

Overview

Participants of this study will get monthly injections with either 25mg or 75mg of the study drug or a placebo (fake injection) over 13 months. You do not choose or know what dose, if any, you receive. Any side effects and benefits will be noted by patient report and through tests like blood draws, physical exam by the study doctor and examination of the colon by endoscopy. During the study you may choose to join a further follow on study or not.

What we're hoping for

To learn if the study drug, SHP647, works to treat moderate to severe Crohn’s Disease and is safe for the patient compared with no treatment (placebo).

Additional Information

ClinicalTrials.gov Identifier: NCT03627091

 Principal Investigator

JeanMarie  Houghton, MD, PhD

University of Massachusetts Medical School

 Study Contact

The Gastrointestinal Research  Office

774-442-4098

IBDClinicalTrials@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989